Workshop "Mastering the Term Sheet: How to Negotiate Value and Control with VCs "

A good valuation is only part of a good VC deal. What about control?
For biotech start-ups and scale-ups, negotiating a term sheet can shape much more than the next financing round. It can determine who makes which decisions, how future value is shared and how much room founders retain to steer their company.

Phillip Dubsky and Sonja Hebenstreit (Herbst Kinsky Rechtsanwälte), together with Joachim Vogt from AbbVie Ventures, will take participants right into the negotiation room in their hands-on workshop “Mastering the Term Sheet: How to Negotiate Value and Control with VCs”.
The workshop will deconstruct a standard VC term sheet, highlight potential pitfalls and put negotiation strategies to the test.